119 related articles for article (PubMed ID: 10311162)
1. Economic aspects of drug substitution.
Salehi H; Schweitzer SO
Health Care Financ Rev; 1985; 6(3):59-68. PubMed ID: 10311162
[TBL] [Abstract][Full Text] [Related]
2. Prescription prices under the New York generic substitution law.
Francetić I; Lasagna L; Weintraub M; Karch FE
Ann Intern Med; 1980 Mar; 92(3):419-23. PubMed ID: 7356236
[TBL] [Abstract][Full Text] [Related]
3. Generic drugs and the prescribing physician.
Nightingale SL; Morrison JC
JAMA; 1987 Sep; 258(9):1200-4. PubMed ID: 3626003
[TBL] [Abstract][Full Text] [Related]
4. Generic script share and the price of brand-name drugs: the role of consumer choice.
Rizzo JA; Zeckhauser R
Int J Health Care Finance Econ; 2009 Sep; 9(3):291-316. PubMed ID: 19130220
[TBL] [Abstract][Full Text] [Related]
5. Potential savings from generic prescribing and generic substitution in South Africa.
Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
[TBL] [Abstract][Full Text] [Related]
6. Cost and price of comparable branded and generic pharmaceuticals.
Bloom BS; Wierz DJ; Pauly MV
JAMA; 1986 Nov; 256(18):2523-30. PubMed ID: 3773152
[TBL] [Abstract][Full Text] [Related]
7. Capitation payment for medicaid pharmacy services: impact on non-medicaid prescriptions.
Lipson DP; Yesalis CE; Kohout FJ; Norwood GJ
Med Care; 1981 Mar; 19(3):342-53. PubMed ID: 7012466
[TBL] [Abstract][Full Text] [Related]
8. The generic prescribing issue.
Brater DC; Pettinger WA
Ann Intern Med; 1980 Mar; 92(3):426-7. PubMed ID: 7356238
[No Abstract] [Full Text] [Related]
9. Generic substitution of antihypertensive drugs: does it affect adherence?
Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
Ann Pharmacother; 2006 Jan; 40(1):15-20. PubMed ID: 16303985
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prescription reimbursement methodologies in Japan and the United States.
Akaho E; MacLaughlin EJ; Takeuchi Y
J Am Pharm Assoc (2003); 2003; 43(4):519-26. PubMed ID: 12952317
[TBL] [Abstract][Full Text] [Related]
11. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.
Haas JS; Phillips KA; Gerstenberger EP; Seger AC
Ann Intern Med; 2005 Jun; 142(11):891-7. PubMed ID: 15941695
[TBL] [Abstract][Full Text] [Related]
12. Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution.
Gumbs PD; Verschuren WM; Souverein PC; Mantel-Teeuwisse AK; de Wit GA; de Boer A; Klungel OH
Br J Clin Pharmacol; 2007 Nov; 64(5):680-5. PubMed ID: 17875197
[TBL] [Abstract][Full Text] [Related]
13. The debate over substitution policy. Its evolution and scientific basis.
Schwartz LL
Am J Med; 1985 Aug; 79(2B):38-44. PubMed ID: 3898831
[TBL] [Abstract][Full Text] [Related]
14. Repackaged pharmaceuticals in the California workers' compensation system: from distribution and pricing options to physician and retail dispensing.
Gitlin M; Wilson L
Am J Ind Med; 2007 Apr; 50(4):303-15. PubMed ID: 17370319
[TBL] [Abstract][Full Text] [Related]
15. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
Bazalo G; Weiss RC
Consult Pharm; 2012 Apr; 27(4):269-73. PubMed ID: 22498986
[TBL] [Abstract][Full Text] [Related]
16. Effect of generic drug competition on the price of prescription drugs in Ontario.
Lexchin J
CMAJ; 1993 Jan; 148(1):35-8. PubMed ID: 8439888
[TBL] [Abstract][Full Text] [Related]
17. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of economic effects of drug product selection legislation.
Goldberg T; DeVito CA; Smith D; Stano M; Vidis JS; Moore WE; Dickson WM
Med Care; 1979 Apr; 17(4):411-9. PubMed ID: 431151
[TBL] [Abstract][Full Text] [Related]
19. The PRICE clinic for low-income elderly: a managed care model for implementing pharmacist-directed services.
Stebbins MR; Kaufman DJ; Lipton HL
J Manag Care Pharm; 2005 May; 11(4):333-41. PubMed ID: 15871644
[TBL] [Abstract][Full Text] [Related]
20. Drug product selection in Illinois: the first year's experience.
Stewart JE; Grussing PG; Purohit AA
Med Care; 1982 Aug; 20(8):831-42. PubMed ID: 7109752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
